A practical 2026 filing guide to the new federal car loan interest deduction created by the 2025 tax law (OBBBA). Covers who qualifies, the US final-assembly requirement and how to verify it, the $10,000 annual cap, MAGI phaseouts for single and joint filers, why non-itemizers still get it, lender reporting on Form 1098-VLI, and common mistakes.
How the 2025 OBBBA 'no tax on overtime' deduction actually works for tax years 2025-2028: FLSA non-exempt eligibility, the $12,500/$25,000 caps, the MAGI phaseout, W-2 Box 12 Code TT reporting, how it differs from the tips deduction, and common filing mistakes.
A practical 2026 guide to active assailant insurance for US businesses: what drives the cost, coverage versus general liability and TRIA terrorism backstop, typical limit ranges, and buying mistakes to avoid.
A practical guide to data center insurance costs in 2026, covering property, business interruption, equipment breakdown, liability and environmental coverage, BESS sublimits, the capacity crunch, and how operators lower premiums through risk engineering.
A practical guide to the Cartiva synthetic cartilage implant recall and federal MDL 3172 litigation. Covers implant subsidence and fracture, revision-to-fusion surgery, eligibility, evidence to gather, statute-of-limitations basics, and contingency-fee structures for U.S. claimants.
A practical 2026 guide to the Eaton Fire and Palisades Fire lawsuits against Southern California Edison: who qualifies to file, categories of recoverable damages, how insurance subrogation interacts with your claim, settlement timelines, contingency fees, and the mistakes that cost survivors money.
VVX (V2X Inc) stock outlook for 2026. A close look at the Vectrus-Vertex merger, the T-6 recompete protest fight, cost-plus versus fixed-price contract mechanics, backlog and book-to-bill trends, deleveraging progress, and what long-term capital gains taxation means for holding VVX.
Q2 Holdings (QTWO) 2026 stock outlook: the Q2 Platform, Helix BaaS, subscription plus transactional revenue, RPO backlog, nCino/Jack Henry/Fiserv/Alkami competition, and the shift toward sustainable free cash flow.
Corcept Therapeutics (CORT) 2026 stock outlook: Korlym's Cushing's syndrome monopoly, generic patent litigation risk, relacorilant's oncology pipeline, and the single-drug concentration risk behind this profitable specialty pharma.
ENR (Energizer Holdings) stock outlook for 2026. A qualitative deep dive into the Energizer, Eveready and Auto Care (Armor All, STP, A/C PRO) brand moat, Duracell and private-label competition, leverage from the 2019 Spectrum Brands deal, and dividend sustainability.
CDE (Coeur Mining) stock outlook for 2026: how Palmarejo, Rochester, Kensington, Wharf, and Las Chispas, now joined by Rainy River and New Afton from the New Gold merger, drive a leveraged bet on gold and silver prices, the Rochester ramp-up, a balance sheet that flipped to net cash, and AISC cost risk.
Patterson-UTI Energy (PTEN) 2026 stock outlook: a qualitative look at the drilling, completions and Ulterra drilling-products segments, the NexTier merger, natural-gas frac fleet conversion, oil-vs-gas activity mix, capital returns and key risks.
A 2026 outlook on EPRT (Essential Properties Realty Trust): the sale-leaseback origination machine behind its net-lease REIT model, granular diversification across car washes, QSRs, early childhood education and auto service tenants, cap-rate spread investing, tenant credit risk, and cost-of-capital sensitivity.
WSFS Financial (WSFS) 2026 stock analysis: the oldest bank in Delaware's net interest margin and deposit beta dynamics, the Bryn Mawr Trust wealth management fee engine, the Cash Connect ATM vault-cash logistics niche, CRE credit exposure, and how WSFS stacks up against peer regional banks.
AGX (Argan Inc) 2026 stock outlook: the Gas-to-Data power-plant EPC backlog boom, fixed-price execution risk, a Quanta/Primoris/MYR Group peer comparison, and US investor tax treatment.
KAI (Kadant Inc) stock outlook for 2026. A close look at the razor-and-blade consumables model behind paper, packaging, and wood-processing equipment, the disciplined bolt-on acquisition machine, industrial-cycle risk, and what US investors should track every quarter.
Samsung Pharm (001360) 2026 stock outlook for international investors: why this KOSPI-listed OTC drugmaker has no ownership link to Samsung Electronics, its Kkasmyeongsu and Woohwangchengsimwon brand moat, the Gemvax & KAEL cross-shareholding, and governance risk.
HL D&I Halla (KRX 014790, formerly Halla Engineering & Construction) 2026 stock outlook: the civil-works-plus-housing business model, Halla Vivaldi brand exposure to unsold units, real estate project-financing risk, HL Group's holding-company ownership structure, and why the stock still trades near 0.3x book value.
Kyungdong City Gas (KRX: 267290) 2026 stock analysis for international investors: the Ulsan-Yangsan regional gas monopoly, the cost pass-through lag built into Korea's tariff system, the Kyungdong Invest holding structure, dividend durability, and electrification risk — framed for access, currency, and withholding considerations.
Mercury Corp (100590) 2026 stock outlook: the rare KOSDAQ vendor supplying Wi-Fi routers to all three Korean carriers, its new FCC-certified Wi-Fi 7 export push, carrier-capex risk, and the quarterly metrics that actually matter.
Samhwa Electronics (011230) stock outlook for 2026: a Korean ferrite-core and soft-magnetic (MPC) maker tied to the Samhwa Condenser Group, pivoting from declining CRT-era parts toward EV power electronics and AI data center power supplies.
Korea Cast Iron Pipe Industries (000970) stock outlook 2026. A qualitative deep dive into its ductile iron pipe business for water and sewage infrastructure, the aging-pipe replacement tailwind, pig iron and scrap cost cycles, and its low-PBR asset-value profile for foreign investors accessing the KRX.
Aluko (KRX 001780) Stock Outlook 2026: the Korean aluminum extruder's shift from window frames toward LG Energy Solution and SK On battery casings, LME pass-through risk, and how US investors can access this small-cap KOSPI name.
Dorco (008000) 2026 stock analysis: how this Korean razor maker survives Gillette and Schick via private-label manufacturing, its overlooked utility-blade business, won-driven margins, low-PBR value traits, and small-float governance risk to weigh.